Rodrigo J Valderrábano1, Jennifer Lee1,2, Li-Yung Lui3, Andrew R Hoffman1,2, Steven R Cummings3, Eric S Orwoll4, Joy Y Wu1. 1. Division of Endocrinology, Stanford University School of Medicine, Stanford, California 94305. 2. Palo Alto Veteran Affairs Health Care System, Palo Alto, California 94304. 3. San Francisco Coordinating Center, California Pacific Medical Center, San Francisco, California 94159. 4. Department of Medicine, Bone and Mineral Unit, Oregon Health and Science University, Portland, Oregon 97239.
Abstract
Context: Extremely low hemoglobin (Hgb) values have been linked to increased fracture risk at different sites. However, careful assessment of clinically defined anemia and fracture risk is lacking. Objective: To determine whether men with anemia were at increased risk of fracture after accounting for bone mineral density (BMD) and bone loss. Design: Cross-sectional analysis (at visit 3) and prospective analysis (from baseline to visit 3) in the Osteoporotic Fractures in Men (MrOS), a multisite, longitudinal cohort study. Setting: Six communities in the United States. Participants: A total of 3632 community-dwelling men (age ≥65 years) in MrOS at baseline (2000 through 2002) who were able to walk unassisted, did not have hip replacement or fracture, and had complete blood cell counts at visit 3 (2007 through 2009). Outcomes: Adjudicated spine and nonspine fractures during a median 7.2 years of follow-up. Results: Analytic baseline characteristics associated with fractures or anemia (defined as Hgb <12 g/dL) were included in multivariable models. Anemia was associated with increased risk of any fracture [hazard ratio (HR), 1.67; 95% confidence interval (CI), 1.26 to 2.21] and nonspine fracture (HR, 1.70; 95% CI, 1.25 to 2.31). A model including change in BMD slightly attenuated the association with any (HR, 1.60; 95% CI, 1.20 to 2.13) and nonspine fractures (HR, 1.57; 95% CI, 1.14 to 2.15). Including absolute BMD did not significantly alter the anemia-fracture association. Anemia was not associated with spine fracture. Conclusions: Community-dwelling older men with anemia had a 57% to 72% increase in nonspine fracture risk independent of BMD and bone loss.
Context: Extremely low hemoglobin (Hgb) values have been linked to increased fracture risk at different sites. However, careful assessment of clinically defined anemia and fracture risk is lacking. Objective: To determine whether men with anemia were at increased risk of fracture after accounting for bone mineral density (BMD) and bone loss. Design: Cross-sectional analysis (at visit 3) and prospective analysis (from baseline to visit 3) in the Osteoporotic Fractures in Men (MrOS), a multisite, longitudinal cohort study. Setting: Six communities in the United States. Participants: A total of 3632 community-dwelling men (age ≥65 years) in MrOS at baseline (2000 through 2002) who were able to walk unassisted, did not have hip replacement or fracture, and had complete blood cell counts at visit 3 (2007 through 2009). Outcomes: Adjudicated spine and nonspine fractures during a median 7.2 years of follow-up. Results: Analytic baseline characteristics associated with fractures or anemia (defined as Hgb <12 g/dL) were included in multivariable models. Anemia was associated with increased risk of any fracture [hazard ratio (HR), 1.67; 95% confidence interval (CI), 1.26 to 2.21] and nonspine fracture (HR, 1.70; 95% CI, 1.25 to 2.31). A model including change in BMD slightly attenuated the association with any (HR, 1.60; 95% CI, 1.20 to 2.13) and nonspine fractures (HR, 1.57; 95% CI, 1.14 to 2.15). Including absolute BMD did not significantly alter the anemia-fracture association. Anemia was not associated with spine fracture. Conclusions: Community-dwelling older men with anemia had a 57% to 72% increase in nonspine fracture risk independent of BMD and bone loss.
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: Zhao Chen; Cynthia A Thomson; Mikel Aickin; J Skye Nicholas; David Van Wyck; Cora E Lewis; Jane A Cauley; Tamsen Bassford Journal: J Am Geriatr Soc Date: 2010-12 Impact factor: 5.562
Authors: Matteo Cesari; Marco Pahor; Fulvio Lauretani; Brenda W H J Penninx; Benedetta Bartali; Roberto Russo; Antonio Cherubini; Richard Woodman; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci Journal: Osteoporos Int Date: 2004-09-28 Impact factor: 4.507
Authors: Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger Journal: Arch Intern Med Date: 2004-05-24
Authors: Adam Greenbaum; Yen-Michael S Hsu; Ryan B Day; Laura G Schuettpelz; Matthew J Christopher; Joshua N Borgerding; Takashi Nagasawa; Daniel C Link Journal: Nature Date: 2013-02-24 Impact factor: 49.962
Authors: Sai Polineni; Megi Resulaj; Alexander T Faje; Erinne Meenaghan; Miriam A Bredella; Mary Bouxsein; Hang Lee; Ormond A MacDougald; Anne Klibanski; Pouneh K Fazeli Journal: J Bone Miner Res Date: 2020-03-23 Impact factor: 6.741
Authors: Rodrigo J Valderrábano; Petra Buzkova; Po-Yin Chang; Neil A Zakai; Howard A Fink; John A Robbins; Jennifer S Lee; Joy Y Wu Journal: Bone Date: 2018-11-15 Impact factor: 4.398
Authors: Kyoung Min Kim; Li-Yung Lui; Jane A Cauley; Kristine E Ensrud; Eric S Orwoll; John T Schousboe; Steven R Cummings Journal: J Bone Miner Res Date: 2020-03-19 Impact factor: 6.741
Authors: R J Valderrábano; J Y Wu; J S Lee; P Buzkova; P-Y Chang; N A Zakai; H A Fink; J A Robbins Journal: Osteoporos Int Date: 2021-02-12 Impact factor: 5.071